| Literature DB >> 31181457 |
Tina Nybo1, Michael J Davies2, Adelina Rogowska-Wrzesinska3.
Abstract
Chlorination of tyrosine is a commonly known effect/consequence of myeloperoxidase activity at sites of inflammation, and detection of 3-chlorotyrosine has been used as biomarker for inflammatory diseases. However, few studies have addressed site specific chlorination in proteins, and no methods for large scale chloroproteomics studies have yet been published. In this study, we present an optimized mass spectrometry based protocol to identify and quantify chlorinated peptides from single proteins modified by HOCl (100 and 500 μM, within estimated pathophysiological levels), at a high level of sensitivity and accuracy. Particular emphasis was placed on 1) sensitive and precise detection of modification sites, 2) the avoidance of loss or artefactual creation of modifications, 3) accurate quantification of peptide abundance and reduction of missing values problem, 4) monitoring the dynamics of modification in samples exposed to different oxidant concentrations and 5) development of guidelines for verification of chlorination sites assignment. A combination of an optimised sample preparation protocol, and improved data analysis approaches have allowed identification of 33 and 15 chlorination sites in laminin and fibronectin, respectively, reported in previous manuscripts [1,2]. The method was subsequently tested on murine basement membrane extract, which contains high levels of laminin in a complex mixture. Here, 10 of the major chlorination sites in laminin were recapitulated, highlighting the utility of the method in detecting damage in complex samples.Entities:
Keywords: Extracellular matrix proteins; Hypochlorous acid; Inflammation; Mass spectrometry; Myeloperoxidase; Protein chlorination; Proteomics
Mesh:
Substances:
Year: 2019 PMID: 31181457 PMCID: PMC6557747 DOI: 10.1016/j.redox.2019.101236
Source DB: PubMed Journal: Redox Biol ISSN: 2213-2317 Impact factor: 11.799
Fig. 1Chlorination analysis workflow. (A) experimental steps of the optimised digestion protocol; (B) data analysis workflow for chlorinated peptide quantification.
Fig. 2Comparison of spin filter-based dialysis and TCA and acetone precipitation in the clean-up of modified protein after exposure to HOCl. Number of (A) unmodified, (B) chlorinated and (C) oxidized peptides, identified in human plasma fibronectin treated with 0 and 500 μM HOCl. n = 2.
Fig. 3Effect of reduction and alkylation steps on the number of identified 3-ClTyr sites in 1.18 μM murine laminin-111 treated with 500 μM HOCl. Protein digestion was performed omitting reduction and alkylation steps, with reduction step alone (10 mM DTT), and with reduction and alkylation (10 mM DTT and 55 mM iodoacetamide). Reported sites were identified by The GPM database search. The peptide lists are available in Supplementary Table S5.
Fig. 4Volcano plots illustrating changes in peptide intensities between reduced (DTT) and non-reduced laminin treated with 500 μM HOCL. (A) all peptides identified; (B) peptides carrying at least one chlorinated residue. Increased and decreased refers to changes in intensity of the same peptide after reduction of the protein with DTT, n = 3.
Protein coverage, digestion efficiency and number of modifications identified in fibronectin using different protein denaturation approaches.
| Denaturants | Coverage [%] | Digestion efficiency [%] | 3-ClTyr | Oxidation (M, C, H) |
|---|---|---|---|---|
| 8 M Urea | 55.6 ± 3.6 | 89.5 | 11 ± 1 | 14 ± 3 |
| 1% SDC | 44.2 ± 3.7 | 91.8 | 21 ± 2 | 13 ± 3 |
| 4 M urea/1% SDC | 51.0 ± 0.1 | 96.5 | 21 ± 2 | 14 ± 1 |
| RapiGest | 46.6 ± 3.6 | 98.1 | 21 ± 3 | 17 ± 3 |
Protein peptide coverage is calculated based on fibronectin protein samples treated with 0, 100, and 500 μM HOCl (urea, SDC and SDC + urea treatments: n = 9, RapiGest treatments: n = 6).
Digestion efficiency is calculated by the number of peptide spectral matches (PSMs) matched to peptides without trypsin missed cleavage sites divided by the total number of PMSs per protein.
The number of modified amino acids found in fibronectin protein treated with 500 μM HOCl (urea, SDC and SDC + urea treatments: n = 9, RapiGest treatments: n = 6). Data were obtained using Mascot search engine and Proteome Discoverer.
Summary of the number of unique modifications identified using the optimized sample preparation protocol extracted from Refs. [1,2]. Fibronectin, murine laminin-111, and murine basement membrane extract (BME) were treated with 500 μM HOCl (n = 3).
| Protein | 3-ClTyr | 3,5-Cl2Tyr | Oxidation (M,C,W, H) | Sequence coverage [%] |
|---|---|---|---|---|
| Fibronectin | 15 | 2 | 7 | 66% |
| Laminin-111 (chain α1) | 33 | 3 | 35 | 51% |
| Laminin from BME | 11 | 5 | 23 | 29% |
Fig. 5(A) - protein map showing peptide sequence coverage from untreated controls. (B) – a total number of modified Tyr, Met, and Trp residues and (C) mean relative site occupancy RSO for modified Tyr, Met and Trp residues in human plasma fibronectin and murine laminin-111 treated with 500 μM HOCl.
Fig. 6(A) RSO of 3-ClTyr residues identified in human fibronectin and laminin α1 after treatment with 500 μM HOCl; (B) MS1 signal intensity of the peptide forms of fibronectin peptide 1881IYLYTLNDNAR1891.